+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 70Years
All Genders
ID07137052

Multi-Center Study on Precision Adaptive Radiotherapy Guidance for Nasopharyngeal Carcinoma Using Advanced Molecular Imaging

Led by The First Affiliated Hospital of Xiamen University · Updated on 2026-08-27

732

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how two special imaging tests, Gallium-68-labeled fibroblast activation protein inhibitor ligand LM3 68Ga-FAPI-LM3 PETCT and Gallium-68-labeled programmed death-ligand 1 68Ga-PD-L1 PETCT, can help with staging and early treatment response prediction in patients with nasopharyngeal carcinoma NPC. This observational study aims to see if 68Ga-FAPI-LM3 PETCT improves the accuracy of NPC staging and if 68Ga-PD-L1 PETCT can predict response to neoadjuvant immunotherapy before treatment begins. The goal is to understand how these imaging methods relate to treatment outcomes and survival. Participants will undergo 68Ga-FAPI-LM3 andor 68Ga-PD-L1 PETCT scans as part of their clinical care or research. The study will measure tumor uptake values like maximum and mean standardized uptake values and other metabolic indices before and after treatment. These imaging results will be analyzed to assess their ability to stage the cancer accurately and predict responses to immunotherapy, comparing findings across patients with different levels of tumor uptake and treatment types. Throughout the study, participants will have their imaging data collected and monitored over time to evaluate treatment response and progression-free survival over three years. Researchers will also analyze overall survival and objective response rates at three years. The study involves regular follow-up visits to track outcomes, and participants must comply with study procedures and attend scheduled assessments to provide necessary clinical information.

CONDITIONS

Brief Title

Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma

Research Team

Q

Qin Lin, Doctor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here